Corrigendum: Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States.

Priyadarshini, Masoom; Prabhu, Vimalanand S; Snedecor, Sonya J; Corman, Shelby; Kuter, Barbara J; Nwankwo, Chizoba; Chirovsky, Diana; Myers, Evan

Priyadarshini, Masoom; Prabhu, Vimalanand S; Snedecor, Sonya J; Corman, Shelby; Kuter, Barbara J; Nwankwo, Chizoba; Chirovsky, Diana; Myers, Evan.

Afiliación

Priyadarshini M; Pharmerit - an OPEN Health Company, Bethesda, MD, United States.
Prabhu VS; Merck & Co. Inc., Kenilworth, NJ, United States.
Snedecor SJ; Pharmerit - an OPEN Health Company, Bethesda, MD, United States.
Corman S; Pharmerit - an OPEN Health Company, Bethesda, MD, United States.
Kuter BJ; Merck & Co. Inc., Kenilworth, NJ, United States.
Nwankwo C; Merck & Co. Inc., Kenilworth, NJ, United States.
Chirovsky D; Merck & Co. Inc., Kenilworth, NJ, United States.
Myers E; Division of Women's Community and Population Health, Department of Obstetrics & Gynecology, Duke University School of Medicine, Durham, NC, United States.

Front Public Health ; 9: 691634, 2021.

Article en En | MEDLINE | ID: mdl-34381752

Palabras clave

cervical cancer; human papillomavirus; mortality; oropharyngeal cancer; productivity loss

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Front Public Health Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google